The patient expired on (b)(6) 2021, after approximately 13.33 days of the prescribed 14-day wear-period.There were ecg transmissions sent to the prescribing physician as part of routine and daily reports on october 8th, 11th, and 13th, 2021.These reports included episodes of ventricular tachycardia (vt) which were appropriately detected and transmitted by the medical device to the independent testing facility (idtf).According to irhythm technologies, inc.'s chief medical and chief scientific officer, the time for medical intervention would have been appropriate as early as october 8, 2021.Investigation into the reported issue has confirmed the device did not malfunction.The available evidence and investigation does not reasonably suggest the device caused or contributed to the reported death.Summary reports are provided for review by the intended user to render a diagnosis based on clinical judgment and experience.The zio at ecg monitoring system is not intended for use on critical care patients.This mdr is being filed due to a retrospective review of complaints per new established criteria for adverse event reporting.The awareness date represents the date this complaint was identified as meeting the new criteria.A follow-up mdr will be submitted should new significant information be obtained relative to this event.
|